ES521728A0 - Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina. - Google Patents

Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.

Info

Publication number
ES521728A0
ES521728A0 ES521728A ES521728A ES521728A0 ES 521728 A0 ES521728 A0 ES 521728A0 ES 521728 A ES521728 A ES 521728A ES 521728 A ES521728 A ES 521728A ES 521728 A0 ES521728 A0 ES 521728A0
Authority
ES
Spain
Prior art keywords
sultamicilina
benzenosulphonic
salt
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521728A
Other languages
English (en)
Spanish (es)
Other versions
ES8406075A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of ES8406075A1 publication Critical patent/ES8406075A1/es
Publication of ES521728A0 publication Critical patent/ES521728A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES521728A 1982-04-23 1983-04-21 Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina. Granted ES521728A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (2)

Publication Number Publication Date
ES8406075A1 ES8406075A1 (es) 1984-07-01
ES521728A0 true ES521728A0 (es) 1984-07-01

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521728A Granted ES521728A0 (es) 1982-04-23 1983-04-21 Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.

Country Status (27)

Country Link
US (1) US4432987A (Direct)
EP (1) EP0092968B1 (Direct)
JP (1) JPS58201792A (Direct)
KR (1) KR860001279B1 (Direct)
AU (1) AU536854B2 (Direct)
CA (1) CA1187484A (Direct)
CS (1) CS235320B2 (Direct)
DD (1) DD209632A5 (Direct)
DE (1) DE3362502D1 (Direct)
DK (1) DK162168C (Direct)
EG (1) EG16412A (Direct)
ES (1) ES521728A0 (Direct)
FI (1) FI76092C (Direct)
GR (1) GR78582B (Direct)
HK (1) HK20588A (Direct)
HU (1) HU187068B (Direct)
IE (1) IE54628B1 (Direct)
IL (1) IL68453A (Direct)
NO (1) NO156202C (Direct)
NZ (1) NZ203988A (Direct)
PH (1) PH18035A (Direct)
PL (1) PL134978B1 (Direct)
PT (1) PT76587B (Direct)
SG (1) SG104087G (Direct)
SU (1) SU1138030A3 (Direct)
YU (1) YU43170B (Direct)
ZA (1) ZA832845B (Direct)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co., Ltd. Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
UA78104C2 (en) 2002-08-29 2007-02-15 Taisho Pharmaceutical Co Ltd Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
DE602004022643D1 (de) * 2003-03-27 2009-10-01 Basilea Pharmaceutica Ag Cephalosporin in kristalliner form
AU2004285533A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
WO2009024823A2 (en) 2007-08-22 2009-02-26 Astrazeneca Ab Oxadiazole derivatives as dgat inhibitors
EP2620432A3 (en) 2007-10-26 2013-12-18 The Regents Of the University of California Diarylhydantoin compounds
WO2010088331A1 (en) * 2009-01-30 2010-08-05 Glaxosmithkline Llc Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
WO2011006061A1 (en) * 2009-07-10 2011-01-13 Evolva Sa Diyne compositions
AU2011218490B9 (en) * 2010-02-18 2014-12-18 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
RU2012139082A (ru) * 2010-02-18 2014-03-27 Астразенека Аб Способы получения производных циклопропиламида и связанных с ними промежуточных соединений
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素ｑ10誘導体およびその製造方法
CN108484469A (zh) * 2013-09-05 2018-09-04 田边三菱制药株式会社 新型结晶性芳烷基胺化合物及其制造方法
UA119794C2 (uk) * 2014-10-21 2019-08-12 Аріад Фармасьютикалз, Інк. Кристалічна форма 5-хлор-n4-[2-(диметилфосфорил)феніл]-n2-{2-метокси-4-[4-(4-метилпіперазин-1-іл)піперидин-1-іл]}піримідин-2,4-діаміну
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
EP3390358B1 (en) * 2016-01-22 2020-09-23 Sandoz AG Crystalline eravacycline bis-hydrochloride
US10889577B2 (en) 2016-07-07 2021-01-12 Cyclerion Therapeutics, Inc. Solid forms of an sGC stimulator
WO2019089540A1 (en) * 2017-10-30 2019-05-09 Theracaine Llc Hydrophobic arenesulfonate salts
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD994822S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1077123S1 (en) 2019-02-13 2025-05-27 Hs Produkt D.O.O. Firearm sight
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
US11957696B2 (en) * 2021-02-15 2024-04-16 Propella Therapeutics, Inc. Abiraterone prodrugs
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
US20240239802A1 (en) * 2021-05-12 2024-07-18 Zhejiang Longcharm Bio-Tech Pharma. Co., Ltd. Crystal form of pyrrolopyrimidine compound and preparation method for crystal form
JP2024520897A (ja) * 2021-05-14 2024-05-27 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビン調節因子の固体形態
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
WO2023125700A1 (zh) * 2021-12-28 2023-07-06 南京明德新药研发有限公司 四氢环庚吲唑化合物的盐型、晶型
EP4525860A2 (en) * 2022-05-20 2025-03-26 Caamtech, Inc. Tryptamine derivatives
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
ZAA202301171S (en) 2023-04-28 2024-09-25 Hs Produkt D O O Firearm
AU2024292586A1 (en) * 2023-07-17 2026-01-29 Kura Oncology, Inc. Crystalline forms of a menin inhibitor
WO2025016385A1 (en) * 2023-07-17 2025-01-23 Kura Oncology, Inc. Pharmaceutical compositions comprising a menin inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
ZA80796B (en) * 1979-02-13 1981-02-25 Leo Pharm Prod Ltd Chemical compounds
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT76587A (en) 1983-05-01
HK20588A (en) 1988-03-25
NO156202B (no) 1987-05-04
CA1187484A (en) 1985-05-21
AU536854B2 (en) 1984-05-24
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
IE54628B1 (en) 1989-12-20
DE3362502D1 (en) 1986-04-17
EP0092968B1 (en) 1986-03-12
FI831392L (fi) 1983-10-24
DK101783A (da) 1983-10-24
FI831392A0 (fi) 1983-04-22
ZA832845B (en) 1984-11-28
IE830926L (en) 1983-10-23
YU90483A (en) 1986-04-30
IL68453A0 (en) 1983-07-31
DD209632A5 (de) 1984-05-16
HU187068B (en) 1985-11-28
DK162168B (da) 1991-09-23
SG104087G (en) 1988-07-15
ES8406075A1 (es) 1984-07-01
FI76092C (fi) 1988-09-09
PL241553A1 (en) 1983-11-21
PH18035A (en) 1985-03-06
KR860001279B1 (ko) 1986-09-05
JPH0119395B2 (Direct) 1989-04-11
IL68453A (en) 1986-08-31
DK101783D0 (da) 1983-02-28
SU1138030A3 (ru) 1985-01-30
YU43170B (en) 1989-04-30
JPS58201792A (ja) 1983-11-24
EP0092968A1 (en) 1983-11-02
KR840004437A (ko) 1984-10-15
NO156202C (no) 1987-08-19
CS235320B2 (en) 1985-05-15
EG16412A (en) 1989-03-30
DK162168C (da) 1992-03-02
US4432987A (en) 1984-02-21
AU1387183A (en) 1983-11-17
FI76092B (fi) 1988-05-31
PL134978B1 (en) 1985-09-30
PT76587B (en) 1986-02-27
GR78582B (Direct) 1984-09-27

Similar Documents

Publication Publication Date Title
ES521728A0 (es) Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES520670A0 (es) Un procedimiento para la preparacion de derivados de acidos alcanoicos.
ES509010A0 (es) Un procedimiento para la produccion de un dl- amino acido o una sal correspondiente.
ES519322A0 (es) Procedimiento para la preparacion de derivados de acidos difosfonicos.
ES521692A0 (es) Un procedimiento para la preparacion de (-)-(r)-1-hidroxi-2--(r-1-metil-3-fenilpropril-aminoetil-salicilamida o una sal de adicion de acido respectiva.
ES534509A0 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES521337A0 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES522883A0 (es) "procedimiento para la preparacion de un ester basico de acido 1, 4-dihidropiridin-3,5-dicarboxilico"
ES535625A0 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma
ES522403A0 (es) Un procedimiento para la preparacion de nuevos compuestos derivados de aziridina.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES518137A0 (es) Procedimiento para la preparacion de n-piridil-amidas de acido 1-fenil-ciclopentancarboxilico.
ES531792A0 (es) Un procedimiento para la preparacion de un compuesto.
ES543491A0 (es) Un procedimiento para la preparacion de una sal metalica de un monoalquilfosfato.
ES500322A0 (es) Procedimiento para la preparacion de un acido bencenocarbo- xilico
ES523786A0 (es) Procedimiento para la preparacion de derivados de acidos difosfonicos.
ES517285A0 (es) Procedimiento para la preparacion de acido metacrilico.
ES523136A0 (es) Un procedimiento para la preparacion de un compuesto.
ES528986A0 (es) Un procedimiento para la preparacion de un compuesto de beta-lactama.
ES538906A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido tiazolilacetico.
ES523869A0 (es) Procedimiento para la preparacion de derivados de acido fenilacetico.
ES518912A0 (es) Un procedimiento para la preparacion de derivados del acido penicilanico.
ES522388A0 (es) Un procedimiento para la preparacion de heptahidrato de 7b-(2d-2-amino-2-carboxietiiitioacetamido-7&-metoxi-3-(1-metil- 1h-tetrazol-5-il)tiometil-3-cefem-4-carboxilato sodico.